Background: Chronic, excess zinc intake can result in copper deficiency and profound neurologic
Copper deficiency is a well-established and increasingly recognized cause of neurologic and hematologic disease. 1, 2 The most common neurologic manifestations of copper deficiency include myelopathy with or without peripheral neuropathy. [1] [2] [3] Less frequently reported, and less clearly causally associated with hypocupremia, are motor neuron disease, 4 peripheral neuropathy in the absence of myelopathy, 5, 6 and optic neuritis. 5 Acquired copper deficiency can result from gastrointestinal surgery, malabsorption, and parenteral feeding deficiency. 1 In addition, excess zinc ingestion has also been established as a cause of hypocupremia. 1, 2 We describe four patients with various neurologic abnormalities who reported chronic use of extremely large amounts of denture cream. The neurologic symptoms of one patient were previously reported in an article focusing on hematologic disease in zinc-induced copper deficiency. 7 Laboratory evaluation revealed hypocupremia, hypoceruloplasminemia, and hyperzincemia in all four patients. In this investigation, we sought to test the hypothesis that excessive use of denture cream was the source of hyperzincemia and hypocupremia. Three formulations of denture cream, including the ones used by our patients, were analyzed for zinc content by dynamic reaction cell-inductively coupled plasma-mass spectrometry. Data from initial and follow-up neurologic, electrodiagnostic, and laboratory testing were also compiled.
METHODS All sample preparations and analyses were conducted at the Mayo Clinic, Rochester, MN, in a Class 10,000 clean room engineered specifically for metal analysis in clinical specimens.
Serum zinc and copper measurements. Evaluation of serum samples from all patients was performed using standard clinical techniques.
Denture cream analysis. Tubes of major brands of denture adhesive (Fixodent Original [n ϭ 5], Super Poli-Grip Original [n ϭ 6], and Super Poli-Grip Extra Care with Polyseal [n ϭ 5]) were purchased in retail stores in Dallas, TX, and Rochester, MN. Lot numbers were different for each tube analyzed. Zinc concentrations were analyzed in duplicate on two separate days for a total of four measurements from each tube of denture cream by dynamic reaction cell-inductively coupled plasma-mass spectrometry (DRC II, Perkin Elmer Instrument, Shelton, CT).
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Case reports. The clinical, laboratory, and radiologic findings of the four patients described in this study are summarized in table 1. A detailed summary of patients 1 and 2 is provided to illustrate both typical and atypical features of these cases. Case 1. A 41-year-old woman presented with a 3.5-year history of numbness and weakness of the arms and legs, progressing to wheelchair dependence. She later developed urinary incontinence and mild cognitive decline. Two years before the onset of her leg weakness, she started wearing dentures and used denture cream, typically two tubes every week. Examination revealed distal greater than proximal weakness, extensor plantar responses, decreased perception of pinprick to the hips, and decreased vibratory sensation and proprioception to the ankles. MRI of the neuraxis was normal. Nerve conduction studies (NCS) and needle electromyography were normal. CSF analysis, routine biochemistry, vitamin B12 studies, and HIV studies were normal. Complete blood count was normal except for white blood cell count of 3.6 ϫ 10 3 /L (4.1-11.1). Serum copper was Ͻ0.1 g/mL (0.75-1.45), serum ceruloplasmin was 0.6 mg/dL (22.9 -43.1), and serum zinc was 2.00 g/mL (0.66 -1.10). She received IV copper supplementation at a dose of 2 mg daily for 5 days followed by oral supplementation. Six weeks after copper supplementation and discontinuation of denture cream, she reported improved sensation, strength, sphincter control, and cognition. Proximal lower extremity strength had improved from Medical Research Council (MRC) grade 3 to 4. Zinc level had improved to1.38 g/mL and copper was 3.39 g/mL. Case 2. A 42-year-old woman presented with a 7-month history of asymmetric hand weakness, most prominent in finger extensors. She also had hand numbness and poor balance. She had worn dentures for many years and used about three tubes of denture cream per week. Her examination revealed severe distal upper extremity weakness and atrophy, distal greater than proximal weakness of the lower extremities, hyperreflexia, extensor plantar responses, and decreased pinprick sensation in the hands. Vibratory sensation and proprioception were normal. Brain MRI showed confluent bifrontal subcortical hyperintense abnormalities on T2 and diffusion-weighted images. MRI of the spine was normal. CSF analysis was unremarkable apart from mildly elevated protein of 59 mg/dL. Serologic testing for HIV, HTLV1 and 2, Lyme, and syphilis was negative. Antinuclear antibodies, erythrocyte sedimentation rate, angiotensin converting enzyme, arylsulfatase A, very long chain fatty acids, serum B12, methylmalonic acid, 24-hour urine heavy metal screen, and plasma porphyrins were normal or negative. NCS and EMG demonstrated an axonal motor neuropathy with active denerva- Table 1 Characteristics of patients using excessive amounts of denture cream *Some of the clinical features of this patient were reported previously.
7 †Patient continued denture cream use. WBC ϭ white blood cell; Hct ϭ hematocrit; NCS ϭ nerve conduction study.
tion in distal muscles. Serum copper was 0.18 g/mL, ceruloplasmin was 3.0 mg/dL, and serum zinc was 1.36 g/mL. The patient was treated with IV copper followed by oral supplementation. She also stopped using denture cream. Six months later, distal hand strength had improved from MRC grade 0 to 2. Copper level was 0.86 g/mL and zinc was 0.98 g/mL.
Cases 3 and 4. Two other patients presented with typical features of myeloneuropathy, hypocupremia, and hyperzincemia in the setting of denture cream use. For patient 4, hematopathologic findings and a summary of neurologic findings have been previously reported.
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RESULTS Concentrations of zinc in denture creams as determined by dynamic reaction cell-inductively coupled plasma-mass spectrometry are summarized in table 2. The relatively small standard deviations among the multiple measurements of zinc made for each brand argue strongly against contamination, a serious obstacle to accurate trace metals analysis.
DISCUSSION
Copper is an essential trace metal, critical to multiple biologic processes including the function of numerous enzymes. 9 Copper deficiency is known to cause neurologic and hematologic disease. [1] [2] [3] [4] [5] [6] [7] [10] [11] [12] Clinical findings of myeloneuropathy associated with copper deficiency resemble those in subacute combined degeneration due to vitamin B12 deficiency. 1, 2 Typical findings include spastic gait, ataxia, and marked dorsal column deficits. While the mechanism by which hypocupremia leads to neurologic abnormality in humans remains uncertain, a similar copper deficiencyassociated myelopathy has been documented in domesticated ruminants (swayback disease). 13 Rarely, neurologic manifestations may occur in the absence of hematologic involvement. 2 Copper deficiency can arise in a variety of clinical settings including malabsorption-associated disease processes (e.g., protein-losing gastroenteropathy, 14 celiac disease, 15 Menkes syndrome 13, 16 ), gastrointestinal surgery, 1,2,10 dietary deficiency (e.g., enteral or total parenteral nutrition 1, 17 ) , and use of copper chelating agents. 18 Ingestion of excess zinc in the form of zinc supplements, denture cream, and coins has also been associated with copper deficiency. 7, 11, 19, 20 Absorption of copper and zinc from ingested material and from salivary, gastric, biliary, and pancreatic secretions occurs by way of specific transporter proteins in small bowel enterocytes. Other transporter proteins regulate metal localization within organelles and efflux into the bloodstream. The labile intracellular pool of the metals is bound by metallothionein, which has a higher affinity for copper than zinc. Excess zinc ingestion upregulates metallothionein production which preferentially sequesters copper in the enterocyte, effectively reducing copper uptake into the body, and ultimately increasing fecal loss. 9, [21] [22] [23] Treatment of Wilson disease with oral zinc exploits this copper chelating mechanism. 23 We report three new patients and summarize neurologic findings on one previously reported patient (patient 4) 7 in whom hypocupremia and hyperzincemia were identified. Each patient wore dentures and used two or more tubes of denture cream per week for years. Evaluation of past medical, surgical, and family history and thorough laboratory testing failed to disclose any other process that could explain the neurologic abnormalities in these patients. Zinc concentrations ranging from about 17,000 to 34,000 g/g were identified in the brands of denture cream used by our patients. No other plausible explanation for zinc excess or copper deficiency was identified. Serum zinc levels improved in three patients with cessation of denture cream use, strongly supporting denture cream as the source of this metal. In contrast, patient 3 continued to use denture cream, and his zinc level remained elevated. Copper supplementation resulted in normalization of copper levels in all four patients, but mild neurologic improvement was noted in only two patients.
The literature currently documents at least 43 patients with myelopathy, peripheral neuropathy, or myeloneuropathy in whom laboratory evaluation identified hypocupremia. The exact number of cases is difficult to determine as some patients have been included in two or more reports. Of the 32 patients for whom serum or urine zinc levels were reported, 25 patients (78%) had elevated values. 1, 2, 3, 7, 11, 12, 24, 31 Notable with respect to accurate laboratory screening for excess zinc intake and excretion, 4 patients with normal serum levels had elevated 24-hour urine levels. 2 However, the source of the hyperzincemia or hyperzincuria was identified in only 4 patients, with a presumed denture cream source noted in one patient (our patient 4) 7 and zinc supplement source noted in three others. 2, 4, 6, 11 Although tooth loss has declined in the United States due to improved preventive dental care and fluoridation of drinking water, many individuals, especially the elderly, wear dentures. Denture adhesive is used to optimize the fit and improve retentive Table 2 Zinc concentration in denture creams measured by dynamic reaction cellinductively coupled plasma-mass spectrometry qualities of a dental prosthesis and thus improve chewing ability and comfort. 25, 26 Few studies have attempted to document the proportion of individuals who wear dentures or the rate of denture adhesive use among denture wearers. It has been estimated that between 6.9 and 33% of denture wearers regularly use denture adhesive, but these data are based in part on an unpublished survey and industry estimates. 25, 26 In a study of 146 denture wearers in South Australia, 32.9% had tried denture adhesive and 6.9% used it on a regular basis; of these, most adhesive users were in the 50 -80 years age group. 26 Recommended instructions for use include application of thin strips or series of dots. With once daily application of a typical amount of 0.5 to 1.5 g per dental unit, 24 a 68 g tube would last about 3 to 10 weeks. In our report, three of the four patients are very atypical in that their edentulous state occurred at a younger age and each used extremely large amounts of denture adhesive daily for years.
Using inductively coupled plasma mass spectrometry, a sensitive and specific technique for the determination of metal content, 8 varying concentrations of zinc were detected in the brands of denture cream used by our patients. Modern denture creams employ calcium-zinc polymers which, with hydration by saliva, establish adhesive and cohesive properties. 25 The polymer is solubilized and adhesiveness is reduced, with the effect increased by hot liquids, possibly requiring reapplication. 25 Inevitably, some of the adhesive is swallowed by the user. Each of our patients used two tubes or more of denture cream per week to optimize the fit of his or her dentures. In addition, patient 4 ingested "pellets" of denture cream. We speculate that the copper deficiency in these four patients was secondary to ingestion of denture cream. Although the patients applied denture cream generously, the amount of ingested zinc cannot be calculated. However, we do know that the denture creams used by the patients in this study contain at least 17 mg of zinc per gram of cream, and application of two standard 68 g tubes or more per week would lead to exposure of at least 330 mg of zinc per day. It is reasonable to assume that the patients' ingestion of zinc exceeded the NIH's recommended daily allowance for adult women (8 mg) and men (11 mg) and may have also exceeded the daily tolerable upper level intake of 40 mg established in 2001 by the National Academy of Sciences. 27 While the neurologic disease in our patients is most likely the result of acquired copper deficiency, a direct neurotoxic effect of elevated zinc cannot be ruled out. Experimental studies in cell culture, isolated mitochondria, and animal models have demonstrated an apparent neurotoxic effect of excess zinc with excitotoxic, apoptotic, and mitochondrial inhibitory pathogenic mechanisms proposed. 9, 22 However, no similar evidence has been reported to date in humans. Most notably, no clinical abnormalities have been identified in affected individuals in two families with hereditary hyperzincemia, and serum copper levels were normal in those affected individuals in whom it was measured. [28] [29] [30] Some atypical clinical features were present in two of our patients. Patient 1 experienced mild cognitive impairment which improved following copper supplementation. Her cognition was not formally evaluated prior to therapy, and therefore we do not have quantitative data to support this improvement. The significance of this finding is uncertain and does not necessarily imply a causal relationship with hypocupremia. Another unusual feature was seen in patient 2 who had predominantly motor, asymmetric weakness, involving the upper extremities more than the lower extremities simulating a motor neuron disease. This phenotype was recently reported in three patients with hypocupremia. 4 Whether the white matter abnormality noted on MRI evaluation in the brain of patient 2 is the result of hypocupremia or another, currently undisclosed etiologic process is uncertain. The most consistent abnormal finding on spine MRI in patients with copper deficiency myelopathy is increased T2 signal in the dorsal columns. The cervical cord is most commonly involved, and contrast enhancement is not present. 3, 12 Several other reports have documented either brain or spinal cord myelin abnormalities on MRI in the setting of copper deficiency-associated neurologic disease, 1, 3, 31, 32 and ingestion of the copper chelator cuprizone has been used as a model of CNS demyelination. 33 This report quantitates the zinc content in commercially available denture creams. It also documents a possible association between markedly excessive denture cream use and hyperzincemia, secondary hypocupremia, and subsequent neurologic symptoms. These findings, while not proving a causal relationship, warrant routine inquiry about the use of denture cream, in addition to zinc supplements, during the clinical evaluation of patients with myeloneuropathy and hematologic dysfunction. Patients should also be advised to seek professional care if they require increasing amounts of denture adhesive for ill-fitting dentures.
